Organoid and microfluidics-based platforms for drug screening in COVID-19

Catherine Verfaillie is professor in the Faculty of Medicine and head of Stem Cell and Developmental Biology at the Katholieke Universiteit Leuven (KU Leuven), Belgium. She is also a member of the LKI - KU Leuven Cancer Institute. Current research interests in Professor Verfaillie’s group include: hematopoiesis, with the ultimate aim of applying this knowledge to innovative cord blood expansion schemes; pluripotent stem cell (PSC)-derived liver (hepatocytes and nonparenchymal liver cells) models; and PSC-derived neurodegeneration models.

Massoud Vosough is an assistant professor in the Stem Cells Biology and Technology Institute, Royan Institute and head of the Regenerative Medicine Department, Tehran, Iran. Current research interests in his group include: interdisciplinary research in stem cell biology and regenerative medicine for the efficient large-scale differentiation of human PSCs toward hepatocyte-like cells, and using human PSC-derived hepatocytes for regenerative medicine and drug assays, to achieve engineered liver structures using hydrogels derived from liver specific-extracellular matrix and to construct a microfluidic device for medical applications.

© 2021 Elsevier Ltd. All rights reserved.

留言 (0)

沒有登入
gif